Trial · NCT03155997
Adverse events848
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
141 to 160 of 848
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hypertriglyceridaemia | Metabolism and nutrition disorders | 150 mg Abemaciclib + Endocrine Therapy | 67 | 2,791 | 82 |
| other | Hypertriglyceridaemia | Metabolism and nutrition disorders | Endocrine Therapy | 45 | 2,800 | 63 |
| other | Hyperuricaemia | Metabolism and nutrition disorders | 150 mg Abemaciclib + Endocrine Therapy | 33 | 2,791 | 44 |
| other | Hyperuricaemia | Metabolism and nutrition disorders | Endocrine Therapy | 13 | 2,800 | 14 |
| other | Hypoalbuminaemia | Metabolism and nutrition disorders | 150 mg Abemaciclib + Endocrine Therapy | 30 | 2,791 | 39 |
| other | Hypoalbuminaemia | Metabolism and nutrition disorders | Endocrine Therapy | 12 | 2,800 | 17 |
| other | Hypokalaemia | Metabolism and nutrition disorders | 150 mg Abemaciclib + Endocrine Therapy | 105 | 2,791 | 126 |
| other | Hypokalaemia | Metabolism and nutrition disorders | Endocrine Therapy | 22 | 2,800 | 31 |
| other | Vitamin d deficiency | Metabolism and nutrition disorders | 150 mg Abemaciclib + Endocrine Therapy | 29 | 2,791 | 33 |
| other | Vitamin d deficiency | Metabolism and nutrition disorders | Endocrine Therapy | 33 | 2,800 | 37 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 571 | 2,791 | 705 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Endocrine Therapy | 876 | 2,800 | 1,117 |
| other | Arthritis | Musculoskeletal and connective tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 9 | 2,791 | 10 |
| other | Arthritis | Musculoskeletal and connective tissue disorders | Endocrine Therapy | 29 | 2,800 | 33 |
| other | Back pain | Musculoskeletal and connective tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 223 | 2,791 | 277 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Endocrine Therapy | 271 | 2,800 | 317 |
| other | Bone pain | Musculoskeletal and connective tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 62 | 2,791 | 75 |
| other | Bone pain | Musculoskeletal and connective tissue disorders | Endocrine Therapy | 93 | 2,800 | 102 |
| other | Joint range of motion decreased | Musculoskeletal and connective tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 24 | 2,791 | 35 |
| other | Joint range of motion decreased | Musculoskeletal and connective tissue disorders | Endocrine Therapy | 29 | 2,800 | 40 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03155997/events?page=8